Hedge Fund - Baker Bros. Advisors

Baker Bros. Advisors is a New York City-based fund launched in 2000 by Julian and Felix Baker.

Seattle Genetics Inc. (NASDAQ:SGEN) is the subject of a new 13D filing issued by Julian Baker and Felix Baker's Baker Bros.

Fresh statistics reveal that the 50 most popular stocks among hedge funds lost 10% in 2015, which practically means that individual investors should have avoided to invest in what hedge funds owned ...

As a new 13D filing with the SEC has revealed, Julian and Felix Bakers' Baker Bros. Advisors amassed a substantial position in the recently public company Beigene Ltd (ADR) (NASDAQ:BGNE).

According to a recent filing with the Securities and Exchange Commission, Julian and Felix Bakers' Baker Bros. Advisors are bullish on Anacor Pharmaceuticals Inc (NASDAQ:ANAC).

According to statistics from Hedge Fund Research, the average hedge fund lost 2.76% in January, compared to a decline of approximately 5% for the S&P 500 benchmark, so hedge funds did outperform the ...

Most equity investments made by hedge funds are based on strong reasoning and comprehensive analysis, so these investment vehicles do not make blind bets without laying out the reasoning behind each...

There are numerous exceptional money managers who have been able to consistently beat broader market benchmarks, which is just one reason why tracking the moves of elite hedge funds can only be considered...

The hedge fund industry closed in negative territory for 2015, marking the fourth year of decline for the industry since 1990.